Over the last 7 days, the United States market has risen by 1.6%, contributing to a substantial 21% increase over the past year, with earnings forecasted to grow by 19% annually. In this environment of robust growth, stocks with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the company's operations and future prospects.

Top 10 Growth Companies With High Insider Ownership In The United States

Name	Insider Ownership	Earnings Growth
Uxin (UXIN)	34.3%	69.4%
Upstart Holdings (UPST)	14.1%	58.9%
Laird Superfood (LSF)	16.6%	115.9%
KVH Industries (KVHI)	16.2%	146.1%
Karman Holdings (KRMN)	15.6%	52.6%
Figure Technology Solutions (FIGR)	25.9%	54.1%
Corcept Therapeutics (CORT)	10.9%	48.9%
Astera Labs (ALAB)	10.1%	30.9%
AppLovin (APP)	27.1%	21.8%
Allegiant Travel (ALGT)	10%	69.9%

Let's dive into some prime choices out of the screener.

GBank Financial Holdings (GBFH)

Simply Wall St Growth Rating: ★★★★★☆

Overview: GBank Financial Holdings Inc. is a bank holding company for GBank, offering banking services to commercial and consumer clients in Nevada, with a market cap of $438.60 million.

Operations: Revenue for GBank Financial Holdings Inc. is primarily derived from its banking segment, totaling $72.89 million.

Insider Ownership: 33.4%

Revenue Growth Forecast: 34.6% p.a.

GBank Financial Holdings demonstrates strong growth potential with forecasted earnings growth of 61.8% per year, outpacing the US market. Insiders have been actively buying shares recently, indicating confidence in the company's future. However, it faces challenges such as a high level of bad loans at 3.8%, and recent index removals could impact investor sentiment. Despite trading below its fair value estimate, its revenue is expected to grow significantly at 34.6% annually, suggesting robust expansion prospects.

Enovix (ENVX)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Enovix Corporation designs, develops, and manufactures lithium-ion battery cells both in the United States and internationally, with a market cap of approximately $1.29 billion.

Operations: The company generates revenue primarily from its Batteries / Battery Systems segment, which amounted to $34.32 million.

Insider Ownership: 11.4%

Revenue Growth Forecast: 38.1% p.a.

Enovix is poised for significant growth, with revenue expected to increase 38.1% annually, surpassing the US market average. Despite a volatile share price and substantial losses (US$38.26 million in Q1 2026), the company aims for profitability within three years. Recent product launches like MX-1 and strategic hires such as Steve Bakos indicate a focus on expanding commercial capabilities in high-performance battery markets, highlighting its potential amidst challenges of scaling operations and achieving profitability.

Super Micro Computer (SMCI)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Super Micro Computer, Inc. develops and sells server and storage solutions based on modular and open-standard architecture globally, with a market cap of approximately $18.97 billion.

Operations: The company's revenue primarily comes from developing and providing high-performance server solutions, amounting to $33.70 billion.

Insider Ownership: 12.8%

Revenue Growth Forecast: 21.7% p.a.

Super Micro Computer, Inc. demonstrates potential for growth with revenue and earnings forecasted to outpace the US market. Despite a volatile share price and lower profit margins than last year, the company trades at a good value relative to peers. Recent strategic alliances enhance its AI infrastructure capabilities, while substantial insider ownership aligns management interests with shareholders. However, legal challenges related to export compliance could impact investor sentiment and future operations.

Next Steps

• Discover the full array of 171 Fast Growing US Companies With High Insider Ownership right here.
• Looking For Alternative Opportunities? The end of cancer? These 33 emerging AI stocks are developing tech that will allow early idenification of life changing disesaes like cancer and Alzheimer's.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.